This study aimed to investigate the effect of irisin on LPS-induced inflammation in RAW 264.7 macrophages through inhibition of the mitogen-activated protein kinase (MAPK) pathway. A network pharmacology-based approach, combined with molecular docking and in vitro validation were performed to identify the biological activity, key targets, and potential pharmacological mechanisms of irisin against LPS-induced inflammation. By matching 100 potential genes of irisin with 1893 ulcerative colitis (UC) related genes, 51 common genes were obtained. Using protein-protein interaction networks (PPI) and component-target network analysis,10 core genes of irisin on UC were further identified. The results of gene ontology (GO) enrichment analysis showed that the molecular mechanisms of irisin on UC were mainly related to major enrichment in the categories of response to xenobiotic stimulus, response to the drug, and negative regulation of gene expression. Molecular docking results showed good binding activity for almost all core component targets. More importantly, MTT assay and flow cytometry results showed that LPS-induced cytotoxicity was reversed by irisin, after coincubation with irisin, the level of IL-12 and IL-23 decreased in LPS-stimulated RAW264.7 macrophages. Irisin pretreatment significantly inhibited the phosphorylation of ERK and AKT and increased the expression of PPAR alpha and PPAR gamma. LPS-induced enhancement of phagocytosis and cell clearance were reversed by irisin pretreatment. Irisin ameliorated LPS-induced inflammation by inhibiting cytotoxicity and apoptosis, and this protective effect may be mediated through the MAPK pathway. These findings confirmed our prediction that irisin plays an anti-inflammatory role in LPS-induced inflammation via the MAPK pathway.

Department of Clinical Laboratory Huaihe Hospital of Henan University Kaifeng China

Zobrazit více v PubMed

Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–468. doi: 10.1038/nature10777. PubMed DOI PMC

Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wojcik D, Magierowska K, Kwiecien S, Mach T, Brzozowski T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep. 2016;68:827–836. doi: 10.1016/j.pharep.2016.04.009. PubMed DOI

Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, Qi L, Zhang M, Wang X, Cui T, Yang LJ, Tang D. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63:514–525. doi: 10.2337/db13-1106. PubMed DOI

Perakakis N, Triantafyllou GA, Fernandez-Real JM, Huh JY, Park KH, Seufert J, Mantzoros CS. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017;13:324–337. doi: 10.1038/nrendo.2016.221. PubMed DOI PMC

Boström PA, Fernández-Real JM. Metabolism: Irisin, the metabolic syndrome and follistatin in humans. Nature reviews Endocrinology. 2014;10:11–12. doi: 10.1038/nrendo.2013.230. PubMed DOI

Huh JY, Mantzoros CS. Irisin physiology, oxidative stress, and thyroid dysfunction: What next? Metabolism: clinical and experimental. 2015;64:765–767. doi: 10.1016/j.metabol.2015.02.009. PubMed DOI

Qiu S, Cai X, Yin H, Zügel M, Sun Z, Steinacker JM, Schumann U. Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis. Metabolism. 2016;65:825–834. doi: 10.1016/j.metabol.2016.02.006. PubMed DOI

Polyzos SA, Mathew H, Mantzoros CS. Irisin: A true, circulating hormone. Metabolism. 2015;64:1611–1618. doi: 10.1016/j.metabol.2015.09.001. PubMed DOI

Wang S, Pan J. Irisin ameliorates depressive-like behaviors in rats by regulating energy metabolism. Biochem Biophys Res Comun. 2016;474:22–28. doi: 10.1016/j.bbrc.2016.04.047. PubMed DOI

Qiao X, Qiao XY, Nie Y, Ma Y, Ma YX, Chen Y, Cheng R, Yin W, Yinrg WY, Hu Y, Xu W, Xu WM, Xu L, Xu LZ. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci Rep. 2016;6:18732. https://doi.org/10.1038/srep18732, https://doi.org/10.1038/srep21053. PubMed DOI PMC

Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, Lu P, Sartini L, Comite MD, Mori G, Benedetto AD, Brunetti G, Yuen T, Sun L, Reseland JE, Colucci S, New MI, Zaidi M, Cinti S, Grano M. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci USA. 2015;112:12157–12162. doi: 10.1073/pnas.1516622112. PubMed DOI PMC

Li DJ, Li YH, Yuan HB, Qu LF, Wang P. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism. 2017;68:31–42. doi: 10.1016/j.metabol.2016.12.003. PubMed DOI

Metsios GS, Moe RH, Kitas GD. Exercise and inflammation. Best Pract Res Clin Rheumatol. 2020;34:101504. doi: 10.1016/j.berh.2020.101504. PubMed DOI

Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest. 2017;47:600–611. doi: 10.1111/eci.12781. PubMed DOI

Hamer M, Sabia S, Batty GD, Shipley MJ, Tabák AG, Singh-Manoux A, Kivimaki M. Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study. Circulation. 2012;126:928–933. doi: 10.1161/CIRCULATIONAHA.112.103879. PubMed DOI PMC

Rana JS, Arsenault BJ, Després J-P, Côté M, Talmud PJ, Ninio E, Jukema JW, Wareham NJ, Kastelein JJP, Khaw K-T, Boekholdt SM. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J. 2011;32:336–344. doi: 10.1093/eurheartj/ehp010. PubMed DOI

Karstoft K, Pedersen BK. Exercise and type 2 diabetes: focus on metabolism and inflammation. Immunol Cell Biol. 2016;94:146–150. doi: 10.1038/icb.2015.101. PubMed DOI

Goh J, Goh KP, Abbasi A. Exercise and Adipose Tissue Macrophages: New Frontiers in Obesity Research? Front Endocrinol (Lausanne) 2016;7:65. doi: 10.3389/fendo.2016.00065. PubMed DOI PMC

Mazur-Bialy AI, Bilski J, Wojcik D, Brzozowski B, Surmiak M, Hubalewska-Mazgaj M, Chmura A, Magierowski M, Magierowska K, Mach T, Brzozowski T. Beneficial effect of voluntary exercise on experimental colitis in mice fed a high-fat diet: the role of irisin, adiponectin and proinflammatory biomarkers. Nutrients. 2017:9. doi: 10.3390/nu9040410. PubMed DOI PMC

Zhu W, Sahar NE, Javaid HMA, Pak ES, Liang G, Wang Y, Ha H, Huh JY. Exercise-induced irisin decreases inflammation and improves NAFLD by competitive binding with MD2. Cells. 2021:10. doi: 10.3390/cells10123306. PubMed DOI PMC

Liu WX, Zhou F, Wang Y, Wang T, Xing JW, Zhang S, Sang LX, Gu SZ, Wang HL. Voluntary exercise protects against ulcerative colitis by up-regulating glucocorticoid-mediated PPAR-gamma activity in the colon in mice. Acta Physiol (Oxf) 2015;215:24–36. doi: 10.1111/apha.12534. PubMed DOI

Pignataro P, Dicarlo M, Zerlotin R, Zecca C, Dell’Abate MT, Buccoliero C, Logroscino G, Colucci S, Grano M. FNDC5/irisin system in neuroinflammation and neurodegenerative diseases: update and novel perspective. Int J Mol Sci. 2021:22. doi: 10.3390/ijms22041605. PubMed DOI PMC

Lu Y, Li G. Auricular acupuncture induces FNDC5/irisin and attenuates obese inflammation in mice. Acupunct Med. 2020;38:264–271. doi: 10.1136/acupmed-2017-011405. PubMed DOI

Geng Z, Fan WY, Zhou B, Ye C, Tong Y, Zhou YB, Xiong XQ. FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress. J Transl Med. 2019;17:107. doi: 10.1186/s12967-019-1857-8. PubMed DOI PMC

Bosma M, Gerling M, Pasto J, Georgiadi A, Graham E, Shilkova O, Iwata Y, Almer S, Soderman J, Toftgard R, Wermeling F, Bostrom EA, Bostrom PA. FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice. Nat Commun. 2016;7:11314. doi: 10.1038/ncomms11314. PubMed DOI PMC

Gonzalez-Gil AM, Elizondo-Montemayor L. The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: a review. Nutrients. 2020:12. doi: 10.3390/nu12061899. PubMed DOI PMC

Metzger CE, Narayanan SA, Elizondo JP, Carter AM, Zawieja DC, Hogan HA, Bloomfield SA. DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone. Sci Rep. 2019;9:15144. doi: 10.1038/s41598-019-51550-w. PubMed DOI PMC

Huangfu LX, Cai XT, Yang JN, Wang HC, Li YX, Dai ZF, Yang RL, Lin XH. Irisin attenuates inflammation in a mouse model of ulcerative colitis by altering the intestinal microbiota. Exp Ther Med. 2021;22:1433. doi: 10.3892/etm.2021.10868. PubMed DOI PMC

Li QF, Lu WT, Zhang Q, Zhao YD, Wu CY, Zhou HF. Proprietary medicines containing Bupleurum chinense DC. (Chaihu) for depression: network meta-analysis and network pharmacology prediction. Front Pharmacol. 2022;13:773537. doi: 10.3389/fphar.2022.773537. PubMed DOI PMC

Liu J, Liu J, Tong X, Peng W, Wei S, Sun T, Wang Y, Zhang B, Li W. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San against ulcerative colitis. Drug Des Devel Ther. 2021;15:3255–3276. doi: 10.2147/DDDT.S319786. PubMed DOI PMC

Li J, Bi H. The effect and mechanism of cypermethrin-induced hippocampal neurotoxicity as determined by network pharmacology analysis and experimental validation. Bioengineered. 2021;12:9279–9289. doi: 10.1080/21655979.2021.2000106. PubMed DOI PMC

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE. PubChem 2019 update: improved access to chemical data. Nucleic acids research. 2019;47:D1102–D1109. doi: 10.1093/nar/gky1033. PubMed DOI PMC

Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic acids research. 2019;47:W357–W364. doi: 10.1093/nar/gkz382. PubMed DOI PMC

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, Kaplan S, Dahary D, Warshawsky D, Guan-Golan Y, Kohn A, Rappaport N, Safran M, Lancet D. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.31–31.30.33. doi: 10.1002/cpbi.5. PubMed DOI

Piñero J, Ramírez-Anguita JM, Saüch-Pitarch J, Ronzano F, Centeno E, Sanz F, Furlong LI. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48:D845–D855. doi: 10.1093/nar/gkz1021. PubMed DOI PMC

Franz M, Lopes CT, Huck G, Dong Y, Sumer O, Bader GD. Cytoscape.js: a graph theory library for visualisation and analysis. Bioinformatics (Oxford, England) 2016;32:309–311. doi: 10.1093/bioinformatics/btv557. PubMed DOI PMC

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering Cv. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607–D613. doi: 10.1093/nar/gky1131. PubMed DOI PMC

Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for annotation, visualization, and integrated discovery. Gen Biol. 2003;4:P3. doi: 10.1186/gb-2003-4-5-p3. PubMed DOI

Rose PW, Prlić A, Altunkaya A, Bi C, Bradley AR, Christie CH, Costanzo LD, Duarte JM, Dutta S, Feng Z, Green RK, Goodsell DS, Hudson B, Kalro T, Lowe R, Peisach E, Randle C, Rose AS, Shao C, Tao Y-P, Valasatava Y, Voigt M, Westbrook JD, Woo J, Yang H, Young JY, Zardecki C, Berman HM, Burley SK. The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res. 2017;45:D271–D281. PubMed PMC

Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comp Chem. 2010;31:455–461. doi: 10.1002/jcc.21334. PubMed DOI PMC

Liu Y, Grimm M, Dai W-T, Hou M-C, Xiao Z-X, Cao Y. CB-Dock: a web server for cavity detection-guided protein-ligand blind docking. Acta Pharmacologica Sinica. 2020;41:138–144. doi: 10.1038/s41401-019-0228-6. PubMed DOI PMC

Miao J, Ye S, Lan J, Ye P, Wen Q, Mei L, Liu X, Lin J, Zhou X, Du S, Liu X, Li H. Nuclear HMGB1 promotes the phagocytic ability of macrophages. Exp Cell Res. 2020;393:112037. doi: 10.1016/j.yexcr.2020.112037. PubMed DOI

Yin C, Hu W, Wang M, Lv W, Jia T, Xiao Y. Irisin as a mediator between obesity and vascular inflammation in Chinese children and adolescents. Nutr Metab Cardiovasc Dis. 2020;30:320–329. doi: 10.1016/j.numecd.2019.09.025. PubMed DOI

Kelly DP. Medicine Irisin, light my fire. Science (New York, NY) 2012;336:42–43. doi: 10.1126/science.1221688. PubMed DOI

Huerta-Delgado AS, Roffe-Vazquez DN, Gonzalez-Gil AM, Villarreal-Calderon JR, Tamez-Rivera O, Rodriguez-Gutierrez NA, Castillo EC, Silva-Platas C, Garcia-Rivas G, Elizondo-Montemayor L. Serum irisin levels, endothelial dysfunction, and inflammation in pediatric patients with type 2 Diabetes Mellitus and metabolic syndrome. J Diabetes Res. 2020;2020:1949415. doi: 10.1155/2020/1949415. PubMed DOI PMC

Lourenco MV, Frozza RL, de Freitas GB, Zhang H, Kincheski GC, Ribeiro FC, Goncalves RA, Clarke JR, Beckman D, Staniszewski A, Berman H, Guerra LA, Forny-Germano L, Meier S, Wilcock DM, de Souza JM, Alves-Leon S, Prado VF, Prado MAM, Abisambra JF, Tovar-Moll F, Mattos P, Arancio O, Ferreira ST, De Felice FG. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med. 2019;25:165–175. doi: 10.1038/s41591-018-0275-4. PubMed DOI PMC

Narayanan SA, Metzger CE, Bloomfield SA, Zawieja DC. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease. FASEB J. 2018;32:4848–4861. doi: 10.1096/fj.201800178R. PubMed DOI PMC

Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. 2006;16(Suppl 1):3–63. doi: 10.1111/j.1600-0838.2006.00520.x. PubMed DOI

Madkour MM, Anbar HS, El-Gamal MI. Current status and future prospects of p38α/MAPK14 kinase and its inhibitors. Eur J Med Chem. 2021;213:113216. doi: 10.1016/j.ejmech.2021.113216. PubMed DOI

Wan Y, Chong L-W, Evans RM. PPAR-gamma regulates osteoclastogenesis in mice. Nature Med. 2007;13:1496–1503. doi: 10.1038/nm1672. PubMed DOI

Zhu W, Yan H, Li S, Nie W, Fan F, Zhu J. PPAR-γ agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-κB pathways. Int Immunopharmacol. 2016;41:24–34. doi: 10.1016/j.intimp.2016.09.028. PubMed DOI

Lei W, Li X, Li L, Huang M, Cao Y, Sun X, Jiang M, Zhang B, Zhang H. Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways. J Ethnopharmacol. 2021;281:114438. doi: 10.1016/j.jep.2021.114438. PubMed DOI

Mirza AZ, Althagafi, Shamshad H. Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications. Eur J Med Chem. 2019;166:502–513. doi: 10.1016/j.ejmech.2019.01.067. PubMed DOI

Liu WX, Wang T, Zhou F, Wang Y, Xing JW, Zhang S, Gu SZ, Sang LX, Dai C, Wang HL. Voluntary exercise prevents colonic inflammation in high-fat diet-induced obese mice by up-regulating PPAR-gamma activity. Biochem Biophys Res Commun. 2015;459:475–480. doi: 10.1016/j.bbrc.2015.02.047. PubMed DOI

Bertin B, Dubuquoy L, Colombel J-F, Desreumaux P. PPAR-gamma in ulcerative colitis: a novel target for intervention. Current Drug Targets. 2013;14:1501–1507. doi: 10.2174/13894501113149990162. PubMed DOI

Decara J, Rivera P, Lopez-Gambero AJ, Serrano A, Pavon FJ, Baixeras E, Rodriguez de Fonseca F, Suarez J. Peroxisome proliferator-activated receptors: experimental targeting for the treatment of inflammatory bowel diseases. Front Pharmacol. 2020;11:730. doi: 10.3389/fphar.2020.00730. PubMed DOI PMC

Wang L, Xie H, Xu L, Liao Q, Wan S, Yu Z, Lin D, Zhang B, Lv Z, Wu Z, Sun X. rSj16 Protects against DSS-induced colitis by inhibiting the PPAR-α signaling pathway. Theranostics. 2017;7:3446–3460. doi: 10.7150/thno.20359. PubMed DOI PMC

Zakaria R, Yaacob WMW, Othman Z, Long I, Ahmad AH, Al-Rahbi B. Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer’s disease. Physiol Res. 2017;66:553–565. doi: 10.33549/physiolres.933480. PubMed DOI

Dat LD, Thao NP, Tai BH, Luyen BTT, Kim S, Koo JE, Koh YS, Cuong NT, Thanh NV, Cuong NX, Nam NH, Kiem PV, Minh CV, Kim YH. Chemical constituents from Kandelia candel with their inhibitory effects on pro-inflammatory cytokines production in LPS-stimulated bone marrow-derived dendritic cells (BMDCs) Bioorg & Med Chem Lett. 2015;25:1412–1416. doi: 10.1016/j.bmcl.2015.02.048. PubMed DOI

Wei WC, Liu CP, Yang WC, Shyur LF, Sheu JH, Chen SS, Yang NS. Mammalian target of rapamycin complex 2 (mTORC2) regulates LPS-induced expression of IL-12 and IL-23 in human dendritic cells. J Leukoc Biol. 2015;97:1071–1080. doi: 10.1189/jlb.2A0414-206RR. PubMed DOI

Brereton CF, Sutton CE, Lalor SJ, Lavelle EC, Mills KH. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J Immunol. 2009;183:1715–1723. doi: 10.4049/jimmunol.0803851. PubMed DOI

Dobreva ZG, Stanilova SA, Miteva LD. The influence of JNK and P38 MAPK inhibition on IL-12P40 and IL-23 production depending on IL12B promoter polymorphism. Cell Mol Biol Lett. 2009;14:609–621. doi: 10.2478/s11658-009-0022-4. PubMed DOI PMC

Lin CH, Yeh SH, Lin CH, Lu KT, Leu TH, Chang WC, Gean PW. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron. 2001;31:841–851. doi: 10.1016/S0896-6273(01)00433-0. PubMed DOI

Edström A, Ekström PAR. Role of phosphatidylinositol 3-kinase in neuronal survival and axonal outgrowth of adult mouse dorsal root ganglia explants. J Neurosci Res. 2003;74:726–735. doi: 10.1002/jnr.10686. PubMed DOI

Huang XL, Xu J, Zhang XH, Qiu BY, Peng L, Zhang M, Gan HT. PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. Inflamm Res. 2011;60:727–734. doi: 10.1007/s00011-011-0325-6. PubMed DOI

Cao X, Fu M, Bi R, Zheng X, Fu B, Tian S, Liu C, Li Q, Liu J. Cadmium induced BEAS-2B cells apoptosis and mitochondria damage via MAPK signaling pathway. Chemosphere. 2021;263:128346. doi: 10.1016/j.chemosphere.2020.128346. PubMed DOI

Wang G, Xu B, Shi F, Du M, Li Y, Yu T, Chen L. Protective effect of methane-rich saline on acetic acid-induced ulcerative colitis via blocking the TLR4/NF-kappaB/MAPK pathway and promoting IL-10/JAK1/STAT3-mediated anti-inflammatory response. Oxid Med Cell Longev. 2019;2019:7850324. doi: 10.1155/2019/7850324. PubMed DOI PMC

Gao W, Wang C, Yu L, Sheng T, Wu Z, Wang X, Zhang D, Lin Y, Gong Y. Chlorogenic Acid attenuates dextran sodium sulfate-induced ulcerative colitis in mice through MAPK/ERK/JNK pathway. Biomed Res Int. 2019;2019:6769789. doi: 10.1155/2019/6769789. PubMed DOI PMC

Setia S, Nehru B, Sanyal SN. Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer. Biomed Pharmacother. 2014;68:1023–1029. doi: 10.1016/j.biopha.2014.09.006. PubMed DOI

Schwanke RC, Marcon R, Meotti FC, Bento AF, Dutra RC, Pizzollatti MG, Calixto JB. Oral administration of the flavonoid myricitrin prevents dextran sulfate sodium-induced experimental colitis in mice through modulation of PI3K/Akt signaling pathway. Mol Nutr Food Res. 2013;57:1938–1949. doi: 10.1002/mnfr.201300134. PubMed DOI

Bai X, Gou X, Cai P, Xu C, Cao L, Zhao Z, Huang M, Jin J. Sesamin enhances Nrf2-mediated protective defense against oxidative stress and inflammation in colitis via AKT and ERK Activation. Oxid Med Cell Longev. 2019;2019:2432416. doi: 10.1155/2019/2432416. PubMed DOI PMC